SecBot SecBot
424B4 ·Filed Jun 8, 2026

NUWE

Nuwellis, Inc.
BEARISH
Impact 7/10
Horizonimmediate Processed4mo ago SEC0001140361-26-024372
Prospectus supplement
Actionable Insight ▼ Bearish

The offering is a certain present dilution event for a micro-cap company with a going-concern risk. The ~30.4% discount and massive potential dilution (760%+ share increase) will pressure the stock. Monitor for the reverse stock split and stockholder approval needed for warrant exercisability; the company may need further capital infusions beyond this raise.

DirectionBearish
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
NUWE ▼ -43.45% at T+20d
SHORT call ✓ call won +43.45% · α vs SPY +44.28% · entry $0.1450 → $0.0820
Next anchor: T+60d due 8w ago
Latest observation: T+53 -79.11% FF3 residual α
Entry = T+0 close
Jun 8, 2026
via day close
T+1d
+0.14%
call -0.14% · α -0.43%
$0.1452
settled 5mo ago
T+5d
-6.07%
call +6.07% · α +8.18%
$0.1362
settled 4mo ago
T+20d
-43.45%
call +43.45% · α +44.28%
$0.0820
settled 4mo ago
T+60d
Pending
due 8w ago

Executive Summary

Nuwellis priced a dilutive emergency capital raise via a 424B4 prospectus supplement, offering up to 1,903,338 shares of common stock (or pre-funded warrants for up to 18,096,662 shares) plus Series C and Series D common warrants at a combined public offering price of $0.30 per unit. The offering is a reasonable best-efforts deal with no minimum, expected to raise up to ~$5.2M net for working capital. The offering price represents a ~30.4% discount to the last closing price of $0.431. This is a certain present dilution event for a company with a $0M market cap, a history of operating losses ($17.5M net loss in FY2025), and only enough cash to fund operations through Q2 2026.

Key Financial Metrics

Offering Size
$6.0M
Dilution
760%
Underwriters
Ladenburg Thalmann & Co. Inc.

Key Facts

  • Offering of up to 1,903,338 shares of common stock (or pre-funded warrants for up to 18,096,662 shares) at $0.30 per unit, with Series C warrants for 60M shares and Series D warrants for 20M shares.
  • Public offering price of $0.30 per share and accompanying common warrants represents a ~30.4% discount to the June 4, 2026 closing price of $0.431.
  • Estimated net proceeds of ~$5.2M if fully subscribed, with no minimum offering requirement; proceeds used for working capital and general corporate purposes.
  • Company had only $2.083M in cash as of March 31, 2026, and stated it had enough cash to fund operations only through Q2 2026.
  • Concurrent private transaction to reprice up to 3,284,788 outstanding warrants to $0.30, subject to stockholder approval.
  • Placement agent is Ladenburg Thalmann & Co. Inc., receiving 9% cash fee ($540K) and warrants for 600K shares at $0.495.
  • Lock-up restrictions apply to officers, directors, and certain stockholders until 15 days after stockholder approval and reverse stock split.

Financial Impact

Up to ~$5.2M net proceeds raised at a ~30.4% discount to market, representing massive dilution: the offering could increase shares outstanding by ~760% (from 2.64M to ~22.64M shares if all pre-funded warrants are exercised).

dilutioncashworking capital

Risk Factors

  • Massive dilution: the offering could increase outstanding shares by ~760% if all pre-funded warrants are exercised.
  • No minimum offering amount — the company may raise significantly less than the $5.2M target, leaving it undercapitalized.
  • Common warrants are contingent on stockholder approval and a reverse stock split; if not obtained, they have no value.
  • Company has a history of operating losses ($17.5M in FY2025), accumulated deficit of $316.3M, and only $2.083M cash as of March 31, 2026.
  • Nasdaq delisting risk due to low bid price and proposed enhanced listing standards.
  • Concurrent warrant reprice transaction adds further dilution if exercised.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B4 Filing (Primary)0001140361-26-024372
Document: 0001140361-26-024372-index-headers.html0001140361-26-024372
Document: 0001140361-26-024372-index.html0001140361-26-024372
Document: 0001140361-26-024372.txt0001140361-26-024372
23 reports for NUWE
Performance horizon
100% Hit rate @ T+20 12 of 12 directional calls Went positive at some point 12 of 12 best @ T+60▲ +96.33%May 22, 2026
Filters
Rows
Reports for NUWE — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
8-K
NEUTRAL ★ 4/10
$0.3221awaiting T+20—$3.07 (+851.69%)
Sep 18, 2026
5w ago
SC 13G/A
NEUTRAL ★ 3/10
$0.8700 $0.5600▼ −35.63%▼ −34.72%$3.07 (+252.34%)
Sep 17, 2026
5w ago
Press Release
BEARISH ★ 6/10
$1.09 $0.5532▲ +49.25%▲ +50.45%$3.07 (−181.23%)
Aug 27, 2026
8w ago
EFFECT
BEARISH ★ 6/10
$0.9900 $0.7915▲ +20.05%▲ +19.95%$3.07 (−209.64%)
Aug 25, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$1.01 $0.8700▼ −13.86%▼ −15.06%$3.07 (+203.50%)
Aug 13, 2026
10w ago
Press Release
BEARISH ★ 7/10
$1.30 $0.7740▲ +40.46%▲ +38.71%$3.07 (−135.80%)
Aug 3, 2026
12w ago
424B5
BEARISH ★ 7/10
$14.49 $7.13▲ +50.78%▲ +52.01%$3.07 (+78.84%)
Jul 31, 2026
12w ago
Press Release
BEARISH ★ 6/10
$1.74 $0.8889▲ +48.91%▲ +51.90%$3.07 (−76.17%)
Jun 16, 2026
18w ago
Press Release
NEUTRAL ★ 2/10
$0.1350 $0.0840▼ −37.78%▼ −37.83%$3.07 (+2170.67%)
Jun 10, 2026
19w ago
8-K
BEARISH ★ 7/10
$0.1520 $0.0869▲ +42.86%▲ +46.93%$3.07 (−1916.71%)
Showing 10 of 23

US Market Status

Market Closed — Opens in 3h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 8, 2026